Mounjaro vs Wegovy: the honest comparison
Mounjaro (tirzepatide) and Wegovy (semaglutide) are the two heavyweight injections, but they are not the same drug. Here is how they differ on mechanism, dosing, side effects, and what the head-to-head data suggest.
Mounjaro (tirzepatide) and Wegovy (semaglutide) are the two heavyweight injections, but they are not the same drug. Here is how they differ on mechanism, dosing, side effects, and what the head-to-head data suggest.
Frequently asked questions
Is Mounjaro more effective than Wegovy?
In the diabetes trial that compared them directly, tirzepatide (the molecule in Mounjaro) led to larger weight and blood-sugar reductions than semaglutide (the molecule in Wegovy), and indirect comparisons of the obesity trials point the same way. But there is no head-to-head weight-loss trial, averages hide big individual variation, and the better drug for you depends on tolerance, coverage, and health history.
What is the actual difference between them?
Wegovy is semaglutide and acts on one hormone pathway, GLP-1. Mounjaro is tirzepatide and acts on two, GLP-1 and GIP. Both are once-weekly injections with similar side effects and the same major warnings. The dual action of tirzepatide is the leading explanation for its larger average weight effect.
Do they have different side effects?
Not really. Both are dominated by gut side effects, nausea, diarrhea, constipation, and vomiting, worst early and after dose increases, and both carry the same thyroid-tumor warning and cautions around pancreatitis and the gallbladder. The main safety difference is that Wegovy has proven cardiovascular benefit in a large trial, while tirzepatide's heart-outcomes data are still maturing.
Can you switch from one to the other?
People do switch, usually for tolerance, cost, coverage, or supply reasons, but it is a prescriber-guided change rather than a swap you make yourself. Dosing does not translate one-to-one between the two drugs, so a clinician sets the starting dose on the new medication and titrates from there.
Which is cheaper?
It varies by insurance, pharmacy, and the manufacturer savings programs in effect at the time, so there is no fixed answer. For many people, whichever their plan covers is effectively the cheaper one. Cost and coverage are worth checking directly with your pharmacy and insurer rather than assuming, since both change often.
By The Peptips Editorial TeamUpdated August 7, 202610 min read
About The Peptips Editorial Team
The Peptips Editorial Team is a small group of researchers dedicated to making GLP-1 information clearer, calmer, and more useful. We read the trials, the FDA labels, and the published literature, and we translate it into posts you can actually use. We do not provide medical advice, we do not accept payment from drug manufacturers or telehealth clinics, and we cite every claim we make. If you find something on this site that's wrong, we want to know, write to us and we'll update it.
Is Mounjaro Insulin? Clearing Up a Common Mix-Up
Mounjaro is an injection used in diabetes, so people reasonably ask if it is insulin. It is not. Here is what Mounjaro actually is, how it differs from insulin, and why the distinction matters for safety.
Zepbound for Sleep Apnea: What the Approval Means
Zepbound is the first drug FDA-approved for obstructive sleep apnea in adults with obesity. Here is how a weight medication came to treat a breathing disorder, what the trial showed, and what it does not replace.
The Wegovy Pill: Oral Semaglutide, Explained
An oral form of semaglutide for weight management brings the question everyone asks: does the pill work as well as the injection? Here is how the tablet differs, what the trials suggest, and the fine print on taking it.
Get the First 30 Days guide.
A printable companion for week one through week four. Free. Delivered instantly.
By subscribing, you agree to our Privacy Policy. One calm email a week. Unsubscribe anytime.